Brixner, Diana
Edelman, Steven V.
Sieradzan, Ray http://orcid.org/0009-0004-9509-8051
Gavin, James R. III
Funding for this research was provided by:
Embecta
Article History
Received: 19 March 2024
Accepted: 24 April 2024
First Online: 21 May 2024
Declarations
:
: Diana Brixner has received consulting fees from Embecta, Tandem, and Sanofi. Steven V Edelman has received consulting fees from Embecta. Ray Sieradzan is an employee of Embecta. James R. Gavin III has received from Embecta and served on advisory boards and/or speaker bureaus for Abbott Diabetes Care, Novo Nordisk, Medtronic, and Boehringer Ingelheim.
: This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.